JPRN-UMIN000003823已完成2 期
Randomized phase II study of biweekly R-CHOP versus biweekly R-CHOP followed by CHASER as induction therapy for high-dose chemotherapy, LEED, and autologous stem-cell transplantation in poor-risk diffuse large B-cell lymphoma (JCOG0908, DLBCL-bi-R-CHOP/CHASER-LEED-rP2 ) - DLBCL-bi-R-CHOP/CHASER-LEED-rP2 (JCOG0908)
Japan Clinical Oncology Group (JCOG)0 个研究点目标入组 70 人开始时间: 2010年6月25日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) History of glaucoma 2) Diabetes mellitus regularly treated with insulin or uncontrollable diabetes mellitus 3) Uncontrollable hypertension 4) Serious cardiac conditions such as coronary disease, myocardiopathy and/or heart failure that requires treatment, and/or arrhythmia treated with antiarrhythmic 5) Positive test for HBs antigen 6) Positive test for HCV antibody 7) Positive test for HIV antibody 8) Interstitial pneumonia, pulmonary fibrosis or severe pulmonary emphysema 9) Other active malignancies 10) Severe infection that requires systemic therapy 11) Fever above 38 degrees Celsius except related to B symptoms 12) Pregnant, possible pregnant, or breastfeeding woman 13) Psychological disease or condition that precludes participation in clinical trial
研究者
相似试验
已完成
2 期
Randomized phase II/III study of R-CHOP versus weekly rituximab plus CHOP for CD20 positive diffuse large B cell lymphoma (JCOG0601)CD20 positive diffuse large B cell lmyphomaJPRN-UMIN000000929Japan Clinical Oncology Group(JCOG)422
进行中（未招募）
1 期
Randomized phase II study of treatment with R-CHOP vs Bortezomib-R-CAP for young patients with poor IPI diffuse large B-cell lymphoma.EUCTR2012-005138-12-ESGELTAMO (Grupo Cooperativo Español de Linfoma/Trasplante Autólogo de Médula Ósea)127
进行中（未招募）
不适用
An Open-label, Randomized, Phase 2 Study of R-CHOP Plus Enzastaurin versus R-CHOP in the First-Line Treatment of Patients with Intermediate and High-Risk Diffuse Large B-Cell Lymphoma - N/AFirst-Line Diffuse Large B-Cell LymphomaMedDRA version: 9.1Level: LLTClassification code 10012855Term: Diffuse large cell lymphoma (Diffuse large B-cell lymphoma) (Working Formulation)EUCTR2008-005496-10-IEEli Lilly and Company100
进行中（未招募）
2 期
JCOG0908: Randomized phase II study of biweekly R-CHOP versus biweekly R-CHOP followed by CHASER as induction therapy for high-dose chemotherapy, LEED, and autologous stem-cell transplantation in poor-risk diffuse large B-cell lymphomaDLBCL, including subtypelymphomatoid granulomatosis(G3)primary mediastinal large B cell lymphomaJPRN-jRCTs031180103YAMAMOTO Kazuhito70
进行中（未招募）
1 期
A trial of CHOP-R therapy with or without acalabrutinib in patients with newly diagnosed Richter's SyndromeEUCTR2017-004401-40-GBniversity of Birmingham105